409 related articles for article (PubMed ID: 2166066)
1. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
[TBL] [Abstract][Full Text] [Related]
2. [Partial deficiency in 21-hydroxylase in certain forms of hirsutism].
Lucisano A; Satta MA; Tripodi R; Mobili L; De Cicco F; Monaco F; Dell'Acqua S; Roche J
C R Seances Soc Biol Fil; 1989; 183(2):117-21. PubMed ID: 2555033
[TBL] [Abstract][Full Text] [Related]
3. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
[TBL] [Abstract][Full Text] [Related]
4. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.
Pang SY; Softness B; Sweeney WJ; New MI
N Engl J Med; 1987 May; 316(21):1295-301. PubMed ID: 3472077
[TBL] [Abstract][Full Text] [Related]
5. Adrenal abnormalities in polycystic ovary syndrome.
Loughlin T; Cunningham S; Moore A; Culliton M; Smyth PP; McKenna TJ
J Clin Endocrinol Metab; 1986 Jan; 62(1):142-7. PubMed ID: 3079598
[TBL] [Abstract][Full Text] [Related]
6. Source localization of androgen excess in adolescent girls.
Ibáñez L; Potau N; Zampolli M; Prat N; Gussinyé M; Saenger P; Vicens-Calvet E; Carrascosa A
J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
[TBL] [Abstract][Full Text] [Related]
7. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
[TBL] [Abstract][Full Text] [Related]
8. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
9. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
[TBL] [Abstract][Full Text] [Related]
10. Androsterone sulfate: physiology and clinical significance in hirsute women.
Zwicker H; Rittmaster RS
J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
[TBL] [Abstract][Full Text] [Related]
11. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
[TBL] [Abstract][Full Text] [Related]
12. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
13. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
14. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
[TBL] [Abstract][Full Text] [Related]
15. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
16. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
Rosenfield RL; Barnes RB; Ehrmann DA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
[TBL] [Abstract][Full Text] [Related]
17. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
20. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]